Adam Schiffenbauer

Dr. Adam Schiffenbauer is a physician scientist and adult rheumatologist serving as the Deputy Head of the Environmental Autoimmunity Group, National Institutes of Health, at the NIH Clinical Center in Bethesda Maryland.  His main areas of research have been on calcinosis assessment and treatment, imaging in myositis, and the environmental factors causing, impacting the phenotype of, and altering the disease course of autoimmune diseases with a particular focus on the idiopathic inflammatory myopathies.  He serves as principal investigator on the first FDA treatment study for calcinosis.  He has multiple projects focused on new medical imaging techniques and methodologies across many methodologies including MRI, CT scan, DEXA scan, infrared imaging, laser speckle contrast imaging, and capillaroscopy.  His work in identifying environmental risk factors has led to the discovery of important gene/environment interactions impacting human disease and his ongoing work to further explore these relationships with the ongoing goal of expanding our knowledge of environmental factors to create new environmental interventions to control and prevent disease.